BGLC vs HPQ · rev $99.0K vs P/E 8.6, rev $44.52B
BioNexus Gene Lab Corp Common stock (BGLC) versus HP Inc (HPQ) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
BGLC currently screens at market cap $6.1M. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Not investment advice. Open the BGLC and HPQ stock pages for the full models.
Not investment advice.